Australia markets close in 1 hour 56 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
317.58+5.77 (+1.85%)
At close: 04:00PM EST
317.73 +0.15 (+0.05%)
After hours: 07:47PM EST
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
3,273,200
2,342,100
2,711,647
1,176,810
2,096,896
Depreciation & amortisation
143,700
125,600
109,515
106,941
72,420
Deferred income taxes
-465,900
-154,600
277,341
167,387
-1,512,325
Stock-based compensation
498,400
441,400
429,461
360,489
325,047
Change in working capital
566,300
-105,200
-54,454
-66,101
238,020
Accounts receivable
-412,300
-274,700
-223,444
-225,587
-108,152
Inventory
-85,100
-92,800
-132,014
-64,047
-31,965
Accounts payable
14,800
31,900
51,276
-22,785
36,554
Other working capital
3,813,600
2,408,500
2,993,707
1,493,879
1,174,762
Other non-cash items
-100,200
11,300
91,932
21,401
12,089
Net cash provided by operating activities
4,046,500
2,643,500
3,253,505
1,569,330
1,270,286
Cash flows from investing activities
Investments in property, plant and equipment
-232,900
-235,000
-259,798
-75,451
-95,524
Acquisitions, net
-295,900
0
-
-1,154,212
-
Purchases of investments
-585,000
-605,200
-450,723
-576,515
-515,389
Sales/maturities of investments
483,100
499,300
809,909
570,860
431,576
Other investing activities
-
-
-
-
-22,821
Net cash used for investing activities
-630,700
-340,900
99,388
-1,235,318
-202,158
Cash flows from financing activities
Debt repayment
-87,500
-47,000
-42,275
-39,185
-33,388
Common stock issued
-
-
-
343,244
289,293
Common stock repurchased
-539,800
-1,561,300
-739,407
-192,015
-350,043
Other financing activities
3,800
5,700
-1,796
4,683
2,079
Net cash used provided by (used for) financing activities
-444,100
-1,478,000
-505,281
126,773
-71,219
Net change in cash
2,896,800
811,200
2,868,164
462,428
990,727
Cash at beginning of period
6,280,200
5,988,900
3,120,681
2,658,253
1,667,526
Cash at end of period
9,251,900
6,800,100
5,988,845
3,120,681
2,658,253
Free cash flow
Operating cash flow
4,046,500
2,643,500
3,253,505
1,569,330
1,270,286
Capital expenditure
-232,900
-235,000
-259,798
-75,451
-95,524
Free cash flow
3,813,600
2,408,500
2,993,707
1,493,879
1,174,762